Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS). (Q38196070)
Jump to navigation
Jump to search
scientific article published on 20 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS). |
scientific article published on 20 February 2014 |
Statements
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS) (English)
Manfred Wirth
Teuvo Tammela
Virgilio Cicalese
Francisco Gomez Veiga
Karl Delaere
Kurt Miller
Andrea Tubaro
Matthias Schulze
Frans Debruyne
Anup Patel
Frederic Lecouvet
Christien Caris
20 February 2014